机构:[1]Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Department of Endocrinology and Metabology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Institute of Nephrology, Jinan, China,[2]Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China,[3]Shandong Medicine and Health Key Laboratory of Clinical Pharmacy, Department of Clinical Pharmacy, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Engineering and Technology Research Center for Pediatric Drug Development, Jinan, China,[4]Department of Endocrinology and Metabology, Weifang Medical University, Shandong Provincial Qianfoshan Hospital, Weifang, China,[5]Institute of Basic Medicine, The First Affiliated Hospital of Shandong First Medical University, Jinan, Shandong Province, China
Shandong
traditional Chinese Medicine Science and
Technology Development Plan Project (No.2017-
169), Shandong Province medical and health
science and technology development plan project
(NO. 2017WS617), the Key Research &
Development Plan of Shandong Province (No.
2018GSF118176), Natural Science Foundation of
China (82000788) and Natural Science Foundation
of Shandong Province (No. ZR2016HQ26).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类|3 区综合性期刊
小类|3 区综合性期刊
最新[2023]版:
大类|3 区综合性期刊
小类|3 区综合性期刊
第一作者:
第一作者机构:[1]Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Department of Endocrinology and Metabology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Institute of Nephrology, Jinan, China,[2]Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China,
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Chen Xinlong,Li Yan,Zhang Zhongwen,et al.Xianling Gubao attenuates high glucose-induced bone metabolism disorder in MG63 osteoblast-like cells[J].PloS one.2022,17(12):e0276328.doi:10.1371/journal.pone.0276328.
APA:
Chen Xinlong,Li Yan,Zhang Zhongwen,Chen Liping,Liu Yaqian...&Zhang Xiaoqian.(2022).Xianling Gubao attenuates high glucose-induced bone metabolism disorder in MG63 osteoblast-like cells.PloS one,17,(12)
MLA:
Chen Xinlong,et al."Xianling Gubao attenuates high glucose-induced bone metabolism disorder in MG63 osteoblast-like cells".PloS one 17..12(2022):e0276328